petvivo, inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. petvivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. petvivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. petvivo, inc, gel-del technologies, inc. and cosmetalife a corporation are all wholly-owned subsidiaries of petvivo holdings, inc.
Company profile
Ticker
PETV
Exchange
Website
CEO
John Lai / David E. Merrill
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Technologies Scan Corp
SEC CIK
Corporate docs
Subsidiaries
PetVivo, Inc. • Gel-Del Technologies, Inc. ...
PETV stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
30 Apr 24
8-K
Departure of Directors or Certain Officers
26 Apr 24
8-K
Departure of Directors or Certain Officers
22 Apr 24
8-K
Departure of Directors or Certain Officers
19 Apr 24
8-K
Entry into a Material Definitive Agreement
16 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Apr 24
8-K
Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer
14 Mar 24
8-K
Termination of a Material Definitive Agreement
11 Mar 24
424B5
Prospectus supplement for primary offering
7 Mar 24
8-K
Other Events
6 Mar 24
Transcripts
PETV
Earnings call transcript
2024 Q3
12 Feb 24
PETV
Earnings call transcript
2024 Q2
14 Nov 23
PETV
Earnings call transcript
2024 Q1
10 Aug 23
PETV
Earnings call transcript
2023 Q3
9 Feb 23
PETV
Earnings call transcript
2023 Q2
10 Nov 22
PETV
Earnings call transcript
2023 Q1
13 Aug 22
PETV
Earnings call transcript
2022 Q4
29 Jun 22
PETV
Earnings call transcript
2022 Q3
11 Feb 22
PETV
Earnings call transcript
2022 Q2
15 Nov 21
Latest ownership filings
4
John Lai
17 Apr 24
4
GARRY N LOWENTHAL
3 Apr 24
3
GARRY N LOWENTHAL
20 Mar 24
SC 13G/A
A.L. Sarroff Fund, LLC
18 Mar 24
SC 13D
CRUDEN STANLEY C
22 Jan 24
SC 13G/A
A.L. Sarroff Fund, LLC
18 Jan 24
4
James Rudolph Martin
2 Jan 24
4
Robert James Rudelius
2 Jan 24
4
Diane M Levitan
2 Jan 24
4
Robert J Costantino
2 Jan 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 55.25 k | 55.25 k | 55.25 k | 55.25 k | 55.25 k | 55.25 k |
Cash burn (monthly) | 54.57 k | 190.15 k | 1.22 mm | 933.54 k | 813.86 k | 637.49 k |
Cash used (since last report) | 396.80 k | 1.38 mm | 8.87 mm | 6.79 mm | 5.92 mm | 4.64 mm |
Cash remaining | -341.55 k | -1.33 mm | -8.82 mm | -6.73 mm | -5.86 mm | -4.58 mm |
Runway (months of cash) | -6.3 | -7.0 | -7.2 | -7.2 | -7.2 | -7.2 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 16 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | Lai John | Common Stock | Buy | Acquire P | No | No | 0.6 | 150,000 | 90.00 k | 1,288,592 |
1 Apr 24 | Garry N Lowenthal | RSU Restricted Stock Unit | Grant | Acquire A | No | No | 0 | 90,000 | 0.00 | 90,000 |
29 Dec 23 | Rudelius Robert James | Stock Option Common Stock | Grant | Acquire A | No | No | 1.06 | 31,780 | 33.69 k | 31,780 |
29 Dec 23 | Martin James Rudolph | Stock Option Common Stock | Grant | Acquire A | No | No | 1.06 | 33,898 | 35.93 k | 33,898 |
News
IZEA Worldwide And 2 Other Stocks Under $3 Insiders Are Buying
18 Apr 24
12 Health Care Stocks Moving In Monday's After-Market Session
8 Apr 24
12 Health Care Stocks Moving In Monday's Pre-Market Session
8 Apr 24
PetVivo Holdings Inc To Terminate ATM Sales Agreement, Dated As Of August 23, 2023 Between Co And With ThinkEquity LLC
11 Mar 24
PetVivo Holdings, Inc. Announces Garry Lowenthal Joins As The Chief Financial Officer
11 Mar 24
Press releases
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA
8 Apr 24
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA
3 Apr 24
SmallCapVoice.com Inc. ("SCV") to Host First Annual Safety Summit featuring Up-and-Coming Public Companies
14 Mar 24
Appearing on Fox Business Tonight: GEVI, PETV, BTC, BULT, SWISF and more…
11 Mar 24
New to The Street Announces its Five Corporate TV Interviews, Airing Episode 561 on the FOX Business Network Monday, March 11, 2024, at 10:30 PM PT
8 Mar 24